Search results
GSK to Pay CureVac Up to €1.4 Billion for Flu, Covid Shots
Bloomberg· 5 hours agoHave a confidential tip for our reporters? GSK Plc agreed to pay as much as €1.4 billion ($1.5...
GSK and CureVac to Restructure Collaboration into New Licensing Agreement
Digital Journal· 4 hours agoGSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, including combinationsCureVac receives €400 ...
GSK plc (GSK): Did This Healthcare Stock Show a Strong Performance in Q1?
Insider Monkey via Yahoo Finance Canada· 6 days agoWe recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we...
GSK Drops as RSV Shot Suffers Fresh Blow With US Recommendation
Bloomberg· 6 days agoGSK Plc slumped after US health officials recommended restricting vaccination with its RSV shot to...
Moderna (MRNA) Shares Decline on RSV Vaccine Efficacy Data
Zacks via Yahoo Finance Canada· 6 days agoModerna (MRNA) stock sinks after new data shows the efficacy of its mRNA-based RSV vaccine fell...
Cancer Rates Surge: Key Biotech Stocks Leading the Charge in Oncology Drug Development
Baystreet· 6 days agoThe biotech sector is actively addressing this need, with recent notable developments from several companies, including: Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), GSK
Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons
Bloomberg via Yahoo Finance Canada· 2 days ago(Bloomberg) -- US scientists haven’t gotten a handle on how to effectively track bird flu, three...
US Inks Vaccine Deal With Moderna as Bird Flu Threat Looms
Bloomberg via Yahoo Finance Canada· 21 hours ago(Bloomberg) -- Moderna Inc. secured nearly $200 million from the US government to speed development...
Moderna RSV Vaccine Efficacy Sinks Over Time, CDC Documents Show
Bloomberg via Yahoo Finance Canada· 7 days ago(Bloomberg) -- Moderna Inc. shares sank after new data showed the efficacy of its RSV shot fell...
Drugmakers Resist FTC, Lawmaker Efforts to Remove Drug Patents
Bloomberg Law· 2 days agoMajor pharmaceutical companies are resisting calls from the Biden administration and Democratic lawmakers to curb patenting practices on high-cost drugs, putting pressure on the federal government ...